Lemaitre Vascular (LMAT) Total Current Liabilities (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Total Current Liabilities came in at $33.4 million in Q1 2026, up 34.85% year-on-year from $24.7 million in Q1 2025, and down 8.13% on a QoQ basis from $36.3 million in Q4 2025.
Lemaitre Vascular (LMAT) Total Current Liabilities (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Total Current Liabilities data on file, last reported at $33.4 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 34.85% year-over-year to $33.4 million in Q1 2026; TTM through Mar 2026 was $33.4 million, a 34.85% increase from a year earlier, with the FY2025 full-year figure at $36.3 million, up 18.68% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $33.4 million, down from $36.3 million in the prior quarter.
- Over the last five years, Total Current Liabilities for LMAT reached as high as $36.3 million in Q4 2025 and fell as low as $18.3 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $27.6 million across 5 years, with a median of $26.8 million in 2024.
- Across the five-year window, Total Current Liabilities decreased 18.09% in 2022 and jumped 34.85% in 2026, its largest moves.
- Year by year, Total Current Liabilities stood at $25.3 million in 2022, then climbed by 17.96% to $29.9 million in 2023, then advanced by 2.44% to $30.6 million in 2024, then grew by 18.68% to $36.3 million in 2025, then slipped by 8.13% to $33.4 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $33.4 million in Q1 2026, $36.3 million in Q4 2025, and $33.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 3.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 8.51 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.54 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.35 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 3.35 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.91 Bn |
| 10 | Lemaitre Vascular | 2.22 Bn | 1.86 Bn | 48.40 Mn | 33.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.37 Mn |
| Dec 31, 2025 | 36.32 Mn |
| Sep 30, 2025 | 33.29 Mn |
| Jun 30, 2025 | 30.82 Mn |
| Mar 31, 2025 | 24.75 Mn |
| Dec 31, 2024 | 30.61 Mn |
| Sep 30, 2024 | 29.34 Mn |
| Jun 30, 2024 | 25.45 Mn |
| Mar 31, 2024 | 26.81 Mn |
| Dec 31, 2023 | 29.88 Mn |
| Sep 30, 2023 | 29.03 Mn |
| Jun 30, 2023 | 25.86 Mn |
| Mar 31, 2023 | 23.90 Mn |
| Dec 31, 2022 | 25.33 Mn |
| Sep 30, 2022 | 23.44 Mn |
| Jun 30, 2022 | 23.41 Mn |
| Mar 31, 2022 | 18.27 Mn |
| Dec 31, 2021 | 21.81 Mn |
| Sep 30, 2021 | 22.11 Mn |
| Jun 30, 2021 | 21.48 Mn |